SUSAN GRIFFING: Open Payments
NPI 1841390820 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 22 payments from 7 companies in 2025. Trend: 2023 $640 · 2024 $670 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $186 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: QULIPTA, Kerendia, NEXLETOL, UBRELVY, GEMTESA, NEXLIZET, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
